Measuring the outcomes of iSIMPATHY
Dr Claire Scullin explains how the iSIMPATHY project has been designed to end up with sustainable scheme to manage polypharmacy that has been rigorously evaluated. By 2022 it […]
Polypharmacy, or the concomitant use of multiple medicines, is estimated to cost $18 billion and account for 8.6 million hospital admissions annually in the European Union. The iSIMPATHY project is designed to tackle the problem. IMI interviewed Dr Clare Scullin and Dr Joanne Brown to find out more about the project.
Dr Claire Scullin explains how the iSIMPATHY project has been designed to end up with sustainable scheme to manage polypharmacy that has been rigorously evaluated. By 2022 it […]
Drs Claire Scullin and Joanne Brown describes how prescribing pharmacists will carry out in-depth medication reviews for hospital inpatients and make any changes needed to prescriptions as part […]
Polypharmacy, or the concomitant use of multiple medicines, is estimated to cost $18 billion and account for 8.6 million hospital admissions annually in the European Union. The iSIMPATHY […]